These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25144243)

  • 1. The oncofetal protein IMP3: a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung.
    Del Gobbo A; Vaira V; Guerini Rocco E; Palleschi A; Bulfamante G; Ricca D; Fiori S; Bosari S; Ferrero S
    J Thorac Oncol; 2014 Nov; 9(11):1656-61. PubMed ID: 25144243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
    Findeis-Hosey JJ; Xu H
    Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
    Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
    Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
    Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
    Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes.
    Del Gobbo A; Morotti A; Colombo AE; Vaira V; Ercoli G; Pesenti C; Bonaparte E; Guerini-Rocco E; Di Cristofori A; Locatelli M; Palleschi A; Ferrero S
    Med Oncol; 2017 Dec; 35(1):2. PubMed ID: 29209838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not.
    Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H
    Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP3 Immunohistochemical Expression Remains Consistent Among All Grades of Gastrointestinal Neuroendocrine Tumors.
    Agostini-Vulaj D; Whitney-Miller CL; Gonzalez RS; McMahon LA; Findeis-Hosey JJ
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):288-293. PubMed ID: 27438513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
    Del Gobbo A; Fusco N; Barella M; Ercoli G; Sciarra A; Palleschi A; Pagni F; Marchiò C; Papotti M; Ferrero S
    Cell Oncol (Dordr); 2018 Dec; 41(6):687-691. PubMed ID: 30182340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
    Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
    Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
    Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
    Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forkhead box A2 transcription factor is expressed in all types of neuroendocrine lung tumors.
    Khoor A; Stahlman MT; Johnson JM; Olson SJ; Whitsett JA
    Hum Pathol; 2004 May; 35(5):560-4. PubMed ID: 15138929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.
    Lantuejoul S; Moro D; Michalides RJ; Brambilla C; Brambilla E
    Am J Surg Pathol; 1998 Oct; 22(10):1267-76. PubMed ID: 9777989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung.
    Song J; Li M; Tretiakova M; Salgia R; Cagle PT; Husain AN
    Arch Pathol Lab Med; 2010 Nov; 134(11):1702-5. PubMed ID: 21043826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.